The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - ARIAD
Stock and Other Ownership Interests - ARIAD
Matching-adjusted indirect comparison (MAIC) of relative efficacy for brigatinib vs. ceritinib and alectinib in crizotinib-resistant anaplastic lymphoma kinase (ALK+) non-small cell lung cancer (NSCLC).
 
Karen L. Reckamp
Consulting or Advisory Role - Amgen; ARIAD; Astellas Pharma; Boehringer Ingelheim; Euclises; Nektar
Research Funding - Adaptimmune (Inst); ARIAD (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Eisai (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst); Xcovery (Inst)
 
Joseph Lee
Employment - Evidera
Research Funding - ARIAD (Inst)
 
Joice Huang
Employment - ARIAD
Stock and Other Ownership Interests - ARIAD
Consulting or Advisory Role - ARIAD
Research Funding - ARIAD
 
Irina Proskorovsky
Employment - Evidera
Research Funding - Evidera
 
William Reichmann
No Relationships to Disclose
 
Mira Krotneva
Employment - Evidera
Research Funding - Evidera
 
David Kerstein
Employment - ARIAD
Stock and Other Ownership Interests - ARIAD
 
Hui Huang
Employment - ARIAD
Stock and Other Ownership Interests - ARIAD